174 related articles for article (PubMed ID: 10529725)
1. Stimulation of dopa decarboxylase activity in striatum of healthy human brain secondary to NMDA receptor antagonism with a low dose of amantadine.
Deep P; Dagher A; Sadikot A; Gjedde A; Cumming P
Synapse; 1999 Dec; 34(4):313-8. PubMed ID: 10529725
[TBL] [Abstract][Full Text] [Related]
2. Human striatal L-dopa decarboxylase activity estimated in vivo using 6-[18F]fluoro-dopa and positron emission tomography: error analysis and application to normal subjects.
Kuwabara H; Cumming P; Reith J; Léger G; Diksic M; Evans AC; Gjedde A
J Cereb Blood Flow Metab; 1993 Jan; 13(1):43-56. PubMed ID: 8417009
[TBL] [Abstract][Full Text] [Related]
3. Acute neuroleptic stimulates DOPA decarboxylase in porcine brain in vivo.
Danielsen EH; Smith D; Hermansen F; Gjedde A; Cumming P
Synapse; 2001 Aug; 41(2):172-5. PubMed ID: 11400183
[TBL] [Abstract][Full Text] [Related]
4. PET studies of net blood-brain clearance of FDOPA to human brain: age-dependent decline of [18F]fluorodopamine storage capacity.
Kumakura Y; Vernaleken I; Gründer G; Bartenstein P; Gjedde A; Cumming P
J Cereb Blood Flow Metab; 2005 Jul; 25(7):807-19. PubMed ID: 15729292
[TBL] [Abstract][Full Text] [Related]
5. Regional striatal DOPA transport and decarboxylase activity in Parkinson's disease.
Kuwabara H; Cumming P; Yasuhara Y; Léger GC; Guttman M; Diksic M; Evans AC; Gjedde A
J Nucl Med; 1995 Jul; 36(7):1226-31. PubMed ID: 7790948
[TBL] [Abstract][Full Text] [Related]
6. Opposite effects of glutamate antagonists and antiparkinsonian drugs on the activities of DOPA decarboxylase and 5-HTP decarboxylase in the rat brain.
Fisher A; Starr MS
Brain Res; 2000 Jun; 868(2):268-74. PubMed ID: 10854579
[TBL] [Abstract][Full Text] [Related]
7. Behavior of fluorinated analogs of L-(3,4-dihydroxyphenyl)alanine and L-threo-(3,4-dihydroxyphenyl)serine as substrates for Dopa decarboxylase.
Borri Voltattorni C; Bertoldi M; Bianconi S; Deng WP; Wong K; Kim I; Herbert B; Kirk KL
Biochem Biophys Res Commun; 2002 Jul; 295(1):107-11. PubMed ID: 12083775
[TBL] [Abstract][Full Text] [Related]
8. Blood-brain transfer and metabolism of 6-[18F]fluoro-L-dopa in rat.
Reith J; Dyve S; Kuwabara H; Guttman M; Diksic M; Gjedde A
J Cereb Blood Flow Metab; 1990 Sep; 10(5):707-19. PubMed ID: 2117017
[TBL] [Abstract][Full Text] [Related]
9. The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography.
Hoffman JM; Melega WP; Hawk TC; Grafton SC; Luxen A; Mahoney DK; Barrio JR; Huang SC; Mazziotta JC; Phelps ME
J Nucl Med; 1992 Aug; 33(8):1472-7. PubMed ID: 1634937
[TBL] [Abstract][Full Text] [Related]
10. In vivo neurochemical effects of the NR2B selective NMDA receptor antagonist CR 3394 in 6-hydroxydopamine lesioned rats.
Sarre S; Lanza M; Makovec F; Artusi R; Caselli G; Michotte Y
Eur J Pharmacol; 2008 Apr; 584(2-3):297-305. PubMed ID: 18342306
[TBL] [Abstract][Full Text] [Related]
11. Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies.
Huang SC; Yu DC; Barrio JR; Grafton S; Melega WP; Hoffman JM; Satyamurthy N; Mazziotta JC; Phelps ME
J Cereb Blood Flow Metab; 1991 Nov; 11(6):898-913. PubMed ID: 1939385
[TBL] [Abstract][Full Text] [Related]
12. Reduced cerebral fluoro-L-dopamine uptake in adult patients suffering from phenylketonuria.
Landvogt C; Mengel E; Bartenstein P; Buchholz HG; Schreckenberger M; Siessmeier T; Scheurich A; Feldmann R; Weglage J; Cumming P; Zepp F; Ullrich K
J Cereb Blood Flow Metab; 2008 Apr; 28(4):824-31. PubMed ID: 17971791
[TBL] [Abstract][Full Text] [Related]
13. Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: effect on adenosine A2A receptors.
Morissette M; Dridi M; Calon F; Hadj Tahar A; Meltzer LT; Bédard PJ; Di Paolo T
Synapse; 2006 Sep; 60(3):239-50. PubMed ID: 16739115
[TBL] [Abstract][Full Text] [Related]
14. Effect of age on markers for monoaminergic neurons of normal and MPTP-lesioned rhesus monkeys: a multi-tracer PET study.
Doudet DJ; Rosa-Neto P; Munk OL; Ruth TJ; Jivan S; Cumming P
Neuroimage; 2006 Mar; 30(1):26-35. PubMed ID: 16378735
[TBL] [Abstract][Full Text] [Related]
15. Cerebral 6-[(18)F]fluoro-L-DOPA (FDOPA) metabolism in pig studied by positron emission tomography.
Danielsen EH; Smith DF; Gee AD; Venkatachalam TK; Hansen SB; Hermansen F; Gjedde A; Cumming P
Synapse; 1999 Sep; 33(4):247-58. PubMed ID: 10421705
[TBL] [Abstract][Full Text] [Related]
16. Microdialysis studies with amantadine and memantine on pharmacokinetics and effects on dopamine turnover.
Quack G; Hesselink M; Danysz W; Spanagel R
J Neural Transm Suppl; 1995; 46():97-105. PubMed ID: 8821045
[TBL] [Abstract][Full Text] [Related]
17. Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms.
Cumming P; Gjedde A
Synapse; 1998 May; 29(1):37-61. PubMed ID: 9552174
[TBL] [Abstract][Full Text] [Related]
18. In vivo regulation of DOPA decarboxylase by dopamine receptors in rat brain.
Cumming P; Ase A; Laliberté C; Kuwabara H; Gjedde A
J Cereb Blood Flow Metab; 1997 Nov; 17(11):1254-60. PubMed ID: 9390657
[TBL] [Abstract][Full Text] [Related]
19. Loss of metabolites from monkey striatum during PET with FDOPA.
Cumming P; Munk OL; Doudet D
Synapse; 2001 Sep; 41(3):212-8. PubMed ID: 11391782
[TBL] [Abstract][Full Text] [Related]
20. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.
Van De Witte SV; Groenewegen HJ; Voorn P
Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
